From the Popular Press: What Your Patients are Reading:

The US FDA has approved the use of Cymbalta^® (duloxetine) for treating fibromyalgia. Cymbalta, an antidepressant, is marketed by drug company Eli Lilly. About 5 million Americans—mostly women—suffer from fibromyalgia, a chronic disorder marked by widespread pain. Before the approval of Cymbalta for treating fibromyalgia, the only approved drug used to treat the condition was Pfizer’s Lyrica, which was approved in June 2007. Scientists are still conducting research to better understand fibromyalgia, but at this time there is no cure. In two 3-month trials, Cymbalta provided significant pain relief compared to placebo in patients with fibromyalgia. Common side effects included nausea, dry mouth, constipation, decreased appetite, and fatigue. Cymbalta is also approved for the treatment of major depressive disorder and generalized anxiety disorder in adults 18 and older.

Read the full text of the article